OFFICIAL LEGAL TITLE
To provide for quality assurance of COVID-19 reimbursements and reporting.
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 117_HR_311.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2021-01-13.
What are the main provisions?
Key points include:
- Reimbursements for COVID-19 testing and treatment will only be granted if approved tests were used.
- Federal agencies will review each reimbursement request, denying or recovering funds if the test was not approved.
- Official COVID-19 case and death counts will be corrected to exclude data based on unapproved tests.
- Knowingly reporting a false COVID-19 diagnosis will result in up to 10 years imprisonment and/or a fine.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Posey, Bill [R-FL-8].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.